Nanocurcumin (Tehran University of Medical Sciences)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNanocurcumin (Tehran University of Medical Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsSignal transducer and activator of transcription 3Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsPeriapical DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTehran University Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTehran University Of Medical SciencesAin Shams University
Inactive CompaniesN/A
Active IndicationsPeriapical DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A